Cancer treatment vitamin C has passed the first phase of clinical trials

Cancer treatment vitamin C has passed the first phase of clinical trials© Fotolia/ Viktorija

Doctors from the USA have successfully completed the first phase of clinical trials for the treatment of cancer of the brain and lung using ultra-high doses of vitamin C exceeding the daily rate approximately a thousand times said in an article published in the journal Cancer Cell.

«The majority of cancer patients, with whom we now work, with pleasure took part in experiments that could save the lives of other patients. At the moment, the results look promising, but until we know whether increases vitamin C efficacy of chemotherapy itself – this will show the second phase of clinical trials,» — said the head of the experiments from the University of Iowa Brian Allen (Bryan Allen).

Interest in vitamin C as the cure for cancer arose about 30 years ago with the filing of Nobel laureate Linus Pauling, when a series of studies has shown possible benefits from its use in tumors. Relatively recently, in 2009, mark Levin from the National institutes of health (NIH) and his colleagues found that vitamin C can fight cancer only if you increase its concentration to extremely high levels.

Two years ago, another group of researchers confirmed this conclusion by destroying the «unbreakable» cancer tumors in mice with large doses of vitamin C, the same amount of ascorbic acid, which contains about 200 oranges. The penetration of vitamin C into cancer cells led to the emergence of a large number of molecules of hydrogen peroxide inside their mitochondria, which proved fatal to the «rebellious» cells.

Allen and his colleagues tested the conclusions of these studies in a clinical trial on 11 volunteers, who suffered from severe forms of cancer of the lungs and brain. Before beginning a course of chemotherapy, scientists portions was injected into their body a huge dose of vitamin C, gradually increasing its concentration in the blood to values that exceed the norm by 300 times.

After this, the normal cycle of chemotherapy in which patients continued to take large doses of vitamin C for seven months of the experiment. Despite the very frequent intake of acid, patients responded well to this treatment and did not suffer from serious side effects. As the researchers note, these experiments proved that vitamin C is safe for healthy cells and cause them consequences, similar to those that occur inside the tumor.

As shown by these experiments, vitamin in all cases or stop the growth tumor, or significantly slowed her progress, extending the life of patients at 4-6 months, even in the case of the most malignant forms of brain cancer. This allowed them to live on 37-40% longer after diagnosis than other cancer patients.

If the second phase of clinical trials will be completed successfully, the vitamin C, as noted by Allen, will not only extend the life of patients and improve its quality, but also significantly reduce treatment costs, as the entire nine-month course of treatment with ascorbic acid costs less than one dose of chemotherapy or immunotherapy.